BlueCrest Capital Management’s Teladoc Health TDOC Stock Holding History

BlueCrest Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,778	Closed	-$628K	–	451
2021 Q2	$628K	Buy	+3,778	New	+$612K	0.01%	411
2020 Q4	–	Sell	-3,010	Closed	-$660K	–	408
2020 Q3	$660K	Buy	3,010 +1,292	+75%	+$274K	0.02%	228
2020 Q2	$328K	Buy	+1,718	New	+$301K	0.02%	203
2019 Q2	–	Sell	-4,000	Closed	-$222K	–	990
2019 Q1	$222K	Buy	+4,000	New	+$244K	0.01%	894

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

BlueCrest Capital Management's TDOC Position: Q3 2021 in Review

BlueCrest Capital Management sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 3,778 shares — an estimated $628K sold.

BlueCrest Capital Management first reported a position in TDOC in Q1 2019 and held it in 4 quarters. The position peaked at $660K in Q3 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

BlueCrest Capital Management reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
BlueCrest Capital Management sold 3,778 Teladoc Health shares in Q3 2021, an estimated $628K.
BlueCrest Capital Management first reported a position in Teladoc Health in Q1 2019 and held it in 4 quarters.
BlueCrest Capital Management's Teladoc Health position peaked at $660K in Q3 2020.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on BlueCrest Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.